RecruitingNot applicableNCT06081400
Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Strasbourg, France
- Principal Investigator
- Afshin GANGI, MD, PhDHôpitaux Universitaires de Strasbourg
- Intervention
- Cryoablation(procedure)
- Enrollment
- 150 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 2024 – 2029
Study locations (13)
- Service d'oncologie/CHU de Besançon, Besançon, France
- Service d'Oncologie Médicale, Service de Radiologie Interventionnelle, Institut BERGONNIE, Bordeaux, France
- Service d'Oncologie Médicale, Service de Radiologie Interventionnelle-Centre François BACLESSE, Caen, France
- Service d'Oncologie Médicale -Centre Georges François LECLERC, Dijon, France
- Service d'Oncologie Médicale, Service de Radiologie Interventionnelle-Centre Léon BERARD, Lyon, France
- Service d'Oncologie Médicale, service de Radiologie Interventionnelle,CHU de Marseille, Hopital La Timone, Marseille, France
- Service de Radiologie-CHU de Nantes, Nantes, France
- Service d'Oncologie Médicale-Centre Antoine LACASSAGNE, Nice, France
- Service d'Oncologie Médicale, Saint-Herblain, France
- Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France
- Service d'Imagerie Interventionnelle, Hôpitaux Universitaires de Strasbourg , France, 67091, Strasbourg, France
- Service d'Oncologie Médicale-Institut Claudius Régaud et Service de Radiologie Interventionnelle, CHU de Toulouse, Toulouse, France
- Service d'Oncologie médicale, Service de Radiologie Interventionnelle- Institut Gustave ROUSSY, Villejuif, France
Collaborators
Direction Générale de l'Offre des Soins (DGOS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06081400 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNCT06268457Arterial Chemoembolization for the Treatment of Desmoid FibromatosisIstituto Ortopedico Rizzoli